AAAAI 2023: Prescription Rate for Systemic Corticosteroids for Asthma Higher in Delta, Omicron Versus Early COVID-19 Wave
Increased prescription rate seen despite overall milder clinical course as evidenced by decreases in emergency visits and hospitalizations for asthma patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.